BOSTON--(BUSINESS WIRE)--Alloy Therapeutics, a biotechnology ecosystem company, announced the launch of its novel AntiClastic™ Antisense Oligonucleotide (AntiClastic ASO) platform, which employs ...

When the drug fomivirsen was approved by the FDA in 1998 for the treatment of cytomegalovirus retinitis in patients with HIV/AIDs, it was hailed as a milestone in drug discovery because it was the ...

What is acromegaly and who does it affect? Acromegaly is a chronic, life-threatening disease triggered by a benign tumour of the pituitary gland causing excessive growth hormone release. Oversupply of ...

GOTEBORG, Sweden & TREVOSE, Pa. & VICTORIA, Australia--(BUSINESS WIRE)--Cortendo AB (publ) [ticker: CORT on NOTC-A], a biopharmaceutical company focused on rare endocrine disorders and other rare ...

Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The "Antisense & RNAi Therapeutics Market by Technology, Route of Administration, Application, and Region 2025-2033" has been added to ...

According to SNS Insider, the global Antisense and RNAi Therapeutics Market was valued at USD 4.15 billion in 2023 and is expected to reach USD 18.48 billion by 2032, registering a compound annual ...

DUBLIN, April 6, 2021 /PRNewswire/ -- The "Antisense Oligonucleotide Therapeutics Market by Target Indication, Type of Therapy, Type of Molecule Type of Generation and Key Geographies: Industry Trends ...

Antisense Therapeutics Limited is an Australia-based company engaged in the research and development of novel antisense pharmaceuticals. The Company operates in two segments: Multiple Sclerosis and ...

Antisense Therapeutics, an Australian biopharmaceutical company developing and commercializing antisense pharmaceuticals for unmet need in rare diseases announces a virtual poster presentation on the ...

GSK is embarking on a journey with CAMP4 Therapeutics, paying $17.5 million upfront to collaborate on regulatory RNA-targeting therapeutics in neurodegenerative and kidney disease indications.

Stoke Therapeutics completed a series A round to support the development of its antisense approach to boost gene expression and treat disease caused by genetic insufficiency. Apple Tree Partners ...